News Releases

Press Releases

Search Press Releases
  
Subscribe for Email Alerts
10/17/2019
8:30 AM ET
Press Release

First Patient Enrolled in Diffusion Pharmaceuticals’ Phase 2 On-Ambulance Clinical Trial with TSC for the Treatment of Stroke

10/17/2019

CHARLOTTESVILLE, Va., Oct. 17, 2019 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (Nasdaq: DFFN), a cutting-edge biotechnology company developing new treatments for life-threatening medical con...

 Continue Reading
9/3/2019
10:30 AM ET
Press Release

Diffusion Pharmaceuticals to Present at the H.C. Wainwright 21st Annual Global Investment Conference

9/3/2019

CHARLOTTESVILLE, Va., Sept. 03, 2019 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (Nasdaq: DFFN), a cutting-edge biotechnology company developing new treatments for life-threatening medical co...

 Continue Reading
8/8/2019
5:15 PM ET
Earnings Release

Diffusion Pharmaceuticals Reports Second Quarter 2019 Financial Results and Provides Business Update

8/8/2019

Company Completes $6.28 Million Registered Direct OfferingFavorable Data Reported in Glioblastoma Multiforme Phase 3 Run-in StudyPhase 2 On-Ambulance TSC Clinical Trial for the Treatment of Stroke Rea...

 Continue Reading
7/23/2019
8:30 AM ET
Press Release

Diffusion Pharmaceuticals Reports Favorable Safety Data for Dose-Escalation Run-in of Phase 3 INTACT Study in Glioblastoma Multiforme Patients

7/23/2019

CHARLOTTESVILLE, Va., July 23, 2019 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (Nasdaq: DFFN), a cutting-edge biotechnology company developing new treatments for life-threatening medical con...

 Continue Reading
5/28/2019
4:05 PM ET
Press Release

Diffusion Pharmaceuticals Inc. Announces Closing of $6.45 Million Offering Priced At-the-Market

5/28/2019

CHARLOTTESVILLE, Va., May 28, 2019 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (Nasdaq: DFFN) (“Diffusion,” the “Company,” “we,” “our” or “us”) today announced the closing of its previously a...

 Continue Reading
5/24/2019
9:00 AM ET
Press Release

Diffusion Pharmaceuticals Inc. Announces $6.45 Million Registered Direct Offering & Private Placement

5/24/2019

CHARLOTTESVILLE, Va., May 24, 2019 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (Nasdaq: DFFN) (“Diffusion,” the “Company,” “we,” “our” or “us”) today announced that it has entered into a defi...

 Continue Reading
5/23/2019
7:30 AM ET
Press Release

Diffusion Pharmaceuticals Receives Notice of Intention to Grant a Patent Related to Use of TSC in Combination with tPA in Ischemic Stroke from European Patent Office

5/23/2019

Two Additional European Patents Issued

CHARLOTTESVILLE, Va., May 23, 2019 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion” or “the Company”), a cutting-edge...

 Continue Reading
Displaying 1 to 7 (of 117 releases)